A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.
Autor(es): Naranjo C A,Lane D,Ho-Asjoe M,Lanctôt K L
Imprenta: Journal of Clinical Pharmacology, v. 30, n. 2, p. 174-180, 1990
Identificador do objeto digital: 10.1002/j.1552-4604.1990.tb03459.x
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Epidemiology ; Guillain-Barre Syndrome - Public health
Data de publicação: 1990